NIBIB is administering the RADx℠ Tech and Advanced Technology Platforms (ATP) programs. These programs are part of the NIH RADx℠ Initiative to increase testing capacity and accessibility for SARS-CoV-2, the virus that causes COVID. In addition, NIBIB is supporting other technology development, imaging approaches, and digital platforms to address the pandemic.
Rapid Acceleration of Diagnostics (RADx℠) Tech and ATP Programs
The RADx Tech and ATP programs are supporting late-stage development of innovative point-of-care, home-based tests, and clinical laboratory tests.
Descriptions of innovative point of care, home-based, improved clinical laboratory tests, and testing products that are increasing the capacity of testing in the U.S.
COVID-19 Research across NIBIB
NIBIB’s Dr. Kaitlyn Sadtler is a study lead and Principal Investigator working with NIH colleagues to test people who were infected with SARS-CoV-2 and developed antibodies but did not develop symptoms. Read about results from this study.
Learn how this collaborative network is using medical imaging and clinical data sciences to reveal unique features of COVID-19. Learn more about this resource.
Videos
View videos about RADx Tech/ATP programs, interviews with the NIBIB Director and more.
Program Contacts
RADxSM Tech/ATP programmatic or technical inquiries: info.radx@poctrn.org
All other RADxSM Tech/ATP Applicants: RADxNIBIB@mail.nih.gov
SBIR/STTR Applicants: NIBIB-SBIR@mail.nih.gov
All others: COVID19NIBIB@nibib.gov
Related Resources
NIBIB announces additional RADx Tech program Phase 2 awards
Learn about clinical trials for treatments and vaccines at HHS Combat COVID
Director’s Message on COVID-19
NIH COVID-19 Information for Applicants/Grantees
Media Inquiries: nibibpress@mail.nih.gov or 301-496-3500
Related News
